Chief, UW Nuclear Medicine Director, UW PET Imaging Center
Nuclear Medicine
Dr. Scott B. Perlman, MD
|
|
Give Review
Dr. Scott B. Perlman is an expert in the field of Nuclear Medicine. Scott Perlman is a published doctor as well. He has 50 publications published. The latest was: Relations between PET-derived measures of thalamic glucose metabolism and EEG alpha power.
Publications
- A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of (131)I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.
- Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.
- Failure of Radioactive Iodine in the Treatment of Hyperthyroidism.
- A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies.
- PET/CT imaging of inflammatory bowel disease.
- Impact of Different Standardized Uptake Value Measures on PET-Based Quantification of Treatment Response.
- (18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison.
- Impact of expectation-maximization reconstruction iterations on the diagnosis of temporal lobe epilepsy with PET.
- WE-C-BRA-07: Assessment of Heterogeneous Treatment Response in Patients with Multiple Solid Tumors.
- Impact of the definition of peak standardized uptake value on quantification of treatment response.
- Presurgical Localization of Parathyroid Adenomas with Magnetic Resonance Imaging at 3.0 T: An Adjunct Method to Supplement Traditional Imaging.
- Surgical decision making in temporal lobe epilepsy: A comparison of [(18)F]FDG-PET, MRI, and EEG.
- Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease.
- Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer.
- PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment.
- The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.
- F-18 FDG PET imaging of GVHD-associated polymyositis.
- Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease.
- The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
- Noninvasive mapping of regional response to segmental allergen challenge using magnetic resonance imaging and [F-18]fluorodeoxyglucose positron emission tomography.
- Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values.
- PET scan-CT correlation: what the chest radiologist needs to know.
- Hypoxia and Exercise Increase the Transpulmonary Passage of 99mTc-Labeled Albumin Particles in Humans.
- Early detection of rejection in pancreas transplantation.
- Apparent filling defects of the liver.
- The rim sign: association with acute cholecystitis.
- The detection of a gastrointestinal bleeding site in patients with liver cirrhosis: which agent to use?
- 123I-iodoamphetamine SPECT brain imaging in alternating hemiplegia.
- Early diagnosis and treatment of pancreas allograft rejection.
- Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patients.
- A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).
- Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures.
- Acute cholecystitis in an animal model: findings on color Doppler sonography.
- Relations between PET-derived measures of thalamic glucose metabolism and EEG alpha power.
- The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies.
- False-negative bone scan in extensive metastatic disease: CT and MR findings.
- Osteosarcoma arising in Paget's disease of the calvarium.
- Preoperative FDG-PET temporal lobe hypometabolism and verbal memory after temporal lobectomy.
- Donor-specific rejection.
- Effect of nicotinic acid on exogenous myocardial glucose utilization.
- Technetium 94m-labeled methoxyisobutyl isonitrile: dosimetry and resting cardiac imaging with positron emission tomography.
- Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques.
- Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.
- Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
- Can thallium-pertechnetate subtraction scanning play a role in the preoperative imaging for minimally invasive parathyroidectomy?
- FDG-PET in inflammatory bowel disease.
- Whole-body positron emission tomography in patients with HIV-1 infection.
- Clinical molecular imaging with PET agents other than 18F-FDG.
- Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging.
Schools
Rosalind Franklin University of Medicine and Science Chicago Medical School
University Wisc Hosps Clins
Doctors Specialties
- Nuclear Medicine
Accepted Insurances
Education
-
University of Wisconsin -
Rosalind Franklin University of Medicine and Science
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649248030 |
| Last Name Of The Provider | PERLMAN |
| First Name Of The Provider | SCOTT |
| View All |
Similar Doctors
|
|
Dr. Karin E. Witte, MD |
|
|
Dr. Nevein F. Ibrahim, MD |